Sharemaestro Newsreel

IDEXX Laboratories (IDXX) Unveils First Dual Species Cardiac Test For Dogs And Cats

3 Healthcare Stocks with Open Questions

3 Healthcare Stocks with Open Questions Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 22.3% gain over …

Technical Reactions to NEO Trends in Macro Strategies

This article provides a technical analysis of Neogenomics Inc. (NYSE: NEO) based on AI models, indicating strong sentiment across all time horizons and compelling upside potential. It outlines three distinct trading strategies (Position, Momentum Breakout, and Risk Hedging) with specific entry, target, and stop-loss …

Twist Bioscience (TWST) stake of 3.5% reported by William Blair Investment Management

William Blair Investment Management, LLC has reported a 3.5% beneficial ownership stake in Twist Bioscience Corp (TWST), totaling 2,174,594 shares. This filing, a Schedule 13G/A, indicates that the investment firm has sole voting power over 1,975,454 shares and sole dispositive power over all 2,174,594 …

Medpace director McCarthy sells $465,131 in company shares

Medpace Holdings director Cornelius P. McCarthy III sold 795 shares of company stock for $465,131 after exercising options to acquire 3,858 shares. Following these transactions, McCarthy directly holds 13,415 shares. The sale comes as Medpace reported strong Q2 2026 financial results, exceeding Wall Street …

RadNet (RDNT) Stock Cools As Record Revenue Meets Profit Pressure

RadNet (RDNT) experienced a slight stock dip despite reporting record Q2 2026 revenue of US$622.7m and US$99.7m in adjusted EBITDA, driven by strong growth in both its core imaging business and Digital Health segment. However, net income and EPS nearly halved due to cost …

BillionToOne, Inc. Class A Signals Robust Growth

Stock splits calendar for:

This article provides a calendar of stock splits scheduled for the week of October 19-25, 2212, with a detailed list for August 12, 2026. It includes company symbols, names, payable dates, optionable status, and the stock split ratios. Additionally, it lists recent news related …

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Medpace Holdings, Inc. (MEDP) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into potential corporate wrongdoing by Medpace Holdings, Inc. (NASDAQ:MEDP) and certain of its officers and/or directors. The firm is encouraging shareholders who purchased Medpace securities prior to April 22, 2025, and still hold them, to …

ICON plc (ICLR) investor files to sell 915 restricted shares under Rule 144

An investor in ICON plc (ICLR) has filed a notice under Rule 144 to sell 915 restricted shares on the NASDAQ. These shares, valued at approximately $150,327.45, stem from restricted stock vesting on August 10, 2026, and the sale will be facilitated by Morgan …

Charles River Laboratories International Inc. stock outperforms competitors on strong trading day

Charles River Laboratories International Inc. (CRL) saw its stock advance by 1.81% to $282.00 on Tuesday, marking its sixth consecutive day of gains. This performance stood out on a generally grim trading day where the S&P 500 Index fell 0.32% and the Dow Jones …

Insider Selling: Charles River Laboratories International (NYSE:CRL) Director Sells $7,901,575.00 in Stock

Charles River Laboratories International Director James Foster sold 28,733 shares of NYSE:CRL stock for approximately $7.9 million at an average price of $275, reducing his direct ownership by 47.63%. This transaction, conducted under a pre-arranged Rule 10b5-1 trading plan, comes amidst generally positive analyst …

Can A New Vitiligo Registry Move The Needle For Thermo Fisher (TMO)?

Thermo Fisher Scientific (NYSE:TMO) mostly sells the instruments and supplies that let other companies do science, not the treatments themselves. So when the company said on July 29 that it had launched the PPD CorEvitas Vitiligo Registry on July 14, to track how patients …

Sotera Health (NASDAQ:SHC) Insider Sells $2,826,000.00 in Stock

Sotera Health insider Michael Rutz sold 150,000 shares of the company's stock for $2,826,000.00, reducing his position by nearly 31%. This sale follows strong quarterly results where the company beat EPS estimates and saw revenue increase by 9.2% year-over-year. Analysts have maintained a "Moderate …

California Court Holds Sexual Orientation Harassment Claims Are Exempt from Arbitration Under the EFAA

A California appellate court has ruled that sexual orientation harassment claims are exempt from arbitration under the Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act of 2021 (EFAA). This decision in Decloedt v. Radnet Management, Inc. affirms that harassment based on sexual …

IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors

IDEXX Laboratories Inc. (IDXX) stock fell 1.53% on Tuesday, closing at $586.64, despite a general downturn in the stock market. The S&P 500 Index and Dow Jones Industrial Average also saw declines of 0.32% and 0.34%, respectively. The company's stock is now 23.81% below …

ICON plc (NASDAQ: ICLR) holder files Form 144 to sell 841 shares

A holder of ICON plc (NASDAQ: ICLR) has filed a Form 144 indicating an intent to sell 841 common shares valued at $138,169.82. The shares were acquired through restricted stock vesting on August 10, 2026, and the sale is planned for August 11, 2026, …

ICON PLC (ICLR) grants 1,324 Restricted Share Units to director Elliott

ICON PLC director Jeffrey Thomas Elliott has been granted 1,324 Restricted Share Units (RSUs) on August 10, 2026. These RSUs, each representing one ordinary share, are scheduled to vest on May 22, 2027, with a nominal conversion price of EUR 0.06 automatically deducted from …

Revvity : Quarterly Report for Quarter Ending July 5, 2026 (Form 10-Q)

Revvity, Inc. released its quarterly report for the quarter ending July 5, 2026, detailing a 1% increase in overall revenue to $729.7 million compared to the prior year. This growth was primarily driven by a 5% increase in the Diagnostics segment, while the Life …

WATERS CORP /DE/ 2Q 2026: Revenue $1.65B, EPS $(1.39) — 10-Q Summary

Waters Corp (WAT) reported its second-quarter 2026 results, showing a significant increase in revenue to $1.65 billion, primarily due to the acquisition of BDS. Despite the revenue growth, the company posted a net loss of $136 million and diluted earnings per share of $(1.39) …

Charles River Laboratories (CRL) EVP LaPlume reports bona fide gift of 257 shares

Joseph W. LaPlume, EVP, Corp Strategy & Develop at Charles River Laboratories International, Inc. (CRL), reported a bona fide gift of 257 shares of common stock on August 10, 2026. This transaction was a disposition at a reported per-share price of $0.00, leaving LaPlume …

Charles River (CRL) director James C. Foster exercises options and sells 28,733 shares

Charles River Laboratories International director James C. Foster exercised stock options for 28,733 shares at $179.66 per share and immediately sold them at $275.00 per share on August 10, 2026, pursuant to a Rule 10b5-1 Trading Plan. This transaction resulted in an approximate pre-tax …

Medpace (MEDP) director exercises 3,858 options and sells 795 common shares

Medpace Holdings, Inc. director Cornelius P. McCarthy III exercised options for 3,858 shares of common stock at $84.36 per share on August 7, 2026, and subsequently sold 795 of these shares at $585.071 per share. The exercised option had vested in 2021 and was …

Form 8K NeoGenomics Inc For: 11 August By Investing.com

This article reports on NeoGenomics Inc.'s Form 8K filing for August 11th. The brief notice confirms the filing, and the article is primarily a placeholder for this regulatory update. No specific details about the content of the 8K filing are provided within this particular …

NeoGenomics announces planned departure of General Counsel Alicia Olivo

NeoGenomics, Inc. announced that Alicia Olivo, Executive Vice President, General Counsel, and Business Development, will depart from her role as General Counsel effective September 21, 2026, and will assist with the transition until October 2, 2026. This news follows the company's strong second-quarter 2026 …

Revvity (RVTY) grows Q2 revenue, boosts cash and plans China diagnostics exit

Revvity (RVTY) reported a 1% increase in Q2 2026 revenue to $729.7 million, with Diagnostics growth offsetting a decline in Life Sciences. The company's gross margin improved to 57.1%, and operating cash flow from continuing operations reached $317.8 million for the first half of …

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SEC Filing (Aug 11, 2026)

This SEC filing (Form 144) for Charles River Laboratories International, Inc. (CRL) details a proposed sale of 6,500 shares of common stock, valued at $1,819,350.00, acquired through the exercise of stock options on August 11, 2026. The transaction was handled by UBS Financial Services, …

FDA panel to review GRAIL’s Galleri multi-cancer blood test in September

The FDA's Molecular and Clinical Genetics Panel will review GRAIL's Galleri multi-cancer blood test on September 23, 2026. This blood test aims to detect cancer signals early through DNA methylation patterns and predict the cancer's origin. The application includes data from over 70,000 participants …

Guardant Health sees strong growth from MRD and screening, boosted by FDA approvals and guideline inclusion.

Guardant Health is experiencing significant growth in its minimal residual disease (MRD) and cancer screening sectors, fueled by recent FDA approvals, increased insurance coverage, and inclusion in clinical guidelines. While competition is expected to intensify, the company is still projected to deliver solid returns …

$1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today

Thermo Fisher Scientific (NYSE: TMO) has significantly outperformed the market over the last decade, with an annualized return of 14.61%. An investment of $1000 in TMO stock 10 years ago would now be valued at $3,885.72. This demonstrates the substantial impact of compounded returns …

Talen Energy (TLN) Raised Guidance In August, So Why The Loss?

On August 5, Talen Energy (NASDAQ:TLN) posted a net loss for the second quarter, and yet the same release raised the company's full-year 2026 outlook and lifted its expectations for 2027 and 2028. That looks like a contradiction until you separate the accounting from …

A Natera Insider's Shares Vested Before the Firm Reported Revenue Surged 38%. Here's How to Read It

Natera's CFO, Michael Burkes Brophy, sold 795 shares worth $216,000 just before the company reported a 38% revenue surge. This transaction was not a discretionary sale but a non-discretionary "sell-to-cover" to meet tax obligations from vested equity awards under a Rule 10b5-1 trading plan. …

RadNet (NASDAQ:RDNT) Stock Price Expected to Rise, Truist Financial Analyst Says

Truist Financial has increased its price target for RadNet (NASDAQ:RDNT) from $90 to $94, maintaining a "buy" rating, which implies a potential 24% upside. This follows RadNet's strong Q2 2026 performance, with revenue up 25% year-over-year to $622.7 million and EPS of $0.29, both …

Hims & Hers Stock Plunges Post Q2 Earnings Miss, Gross Margin Down

Hims & Hers Health, Inc. HIMS reported quarterly adjusted loss per share of 10 cents in second-quarter 2026, against the year-ago period's adjusted earnings per share (EPS) of 17 cents. The metric was wider than the Zacks Consensus Estimate of loss per share of …

IDEXX (IDXX) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Mike Erickson Chief Financial Officer - Andrew Emerson Vice President, Investor Relations - John Ravis Full Conference Call Transcript Operator: Good morning, …

Waters Corporation stock hits 52-week high at $414.15

Waters Corporation (WAT) stock reached a new 52-week high of $414.15, marking a 47.43% increase over the past year and a 25% gain in the last six months. Despite trading at a high P/E ratio of 185.8 and being considered overvalued by InvestingPro analysis, …